Protective Effects of Melatonin and N-Acetylcysteine on Hepatic Injury in a Rat Cardiopulmonary Bypass Model

Journal of Surgical Research

Volumn 142, Issue 1, 2007, Pages 153-161

  Huang, Hairong ^a   Yin, Rong ^a   Zhu, Jiaquan ^a   Feng, Xiaomei ^a   Wang, Changtian ^a   Sheng, Yi ^a   Dong, Guohua ^a   Li, Demin ^a   Jing, Hua ^a  

^a JINLING HOSPITAL   (China)

Author keywords

cardiopulmonary bypass; hepatic injury; melatonin; N acetylcysteine; oxidative stress; rat; systemic inflammation response

Indexed keywords

ACETYLCYSTEINE; ALANINE AMINOTRANSFERASE; ANTIOXIDANT; ASPARTATE AMINOTRANSFERASE; GLUTATHIONE; INDUCIBLE NITRIC OXIDE SYNTHASE; LIVER ENZYME; MALONALDEHYDE; MELATONIN; MYELOPEROXIDASE; PLACEBO; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; CARDIOPULMONARY BYPASS; CELL SWELLING; CONTROLLED STUDY; DRUG EFFICACY; ENZYME ACTIVITY; GLUTATHIONE METABOLISM; HISTOPATHOLOGY; LIVER INJURY; LIVER PROTECTION; LIVER SINUSOID; MALE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT;

ACETYLCYSTEINE; ANIMALS; APOPTOSIS; CARDIOPULMONARY BYPASS; DISEASE MODELS, ANIMAL; FREE RADICAL SCAVENGERS; GLUTATHIONE; LIVER; MALE; MALONDIALDEHYDE; MELATONIN; NITRIC OXIDE SYNTHASE; OXIDATIVE STRESS; PEROXIDASE; RANDOM ALLOCATION; RATS; RATS, SPRAGUE-DAWLEY; REPERFUSION INJURY; TUMOR NECROSIS FACTOR-ALPHA;

EID: 34547936148     PISSN: 00224804     EISSN: 10958673     Source Type: Journal    
DOI: 10.1016/j.jss.2006.12.553     Document Type: Article

References (34)

1. Chaney M.A. Corticosteroids and cardiopulmonary bypass: A review of clinical investigations. Chest 121 (2002) 921
2. Hannan E.L., Kilburn Jr. H., O'Donnell J.F., et al. Adult open heart surgery in New York State. An analysis of risk factors and hospital mortality rates. JAMA 264 (1990) 2768
3. Starkopf J., Tamme K., Zilmer M., et al. The evidence of oxidative stress in cardiac surgery and septic patients: A comparative study. Clin Chim Acta 262 (1997) 77
4. Paparella D., Yau T.M., and Young E. Cardiopulmonary bypass induced inflammation: Pathophysiology and treatment. An update. Eur J Cardiothorac Surg 21 (2002) 232
5. Vaage J., and Valen G. Pathophysiology and mediators of ischemia-reperfusion injury with special reference to cardiac surgery. A review. Scand J Thorac Cardiovasc Surg Suppl 41 (1993) 1
6. Edmunds Jr. L.H. Inflammatory response to cardiopulmonary bypass. Ann Thorac Surg 66 (1998) S12 Discussion S25.
7. Jeroudi M.O., Hartley C.J., and Bolli R. Myocardial reperfusion injury: Role of oxygen radicals and potential therapy with antioxidants. Am J Cardiol 73 (1994) 2B
8. Lentsch A.B., Kato A., Yoshidome H., et al. Inflammatory mechanisms and therapeutic strategies for warm hepatic ischemia/reperfusion injury. Hepatology 32 (2000) 169
9. Jaeschke H., and Farhood A. Neutrophil and Kupffer cell-induced oxidant stress and ischemia-reperfusion injury in rat liver. Am J Physiol 260 (1991) G355
10. Jaeschke H., Farhood A., and Smith C.W. Neutrophils contribute to ischemia/reperfusion injury in rat liver in vivo. FASEB J 4 (1990) 3355
11. Demir S., and Inal-Erden M. Pentoxifylline and N-acetylcysteine in hepatic ischemia/reperfusion injury. Clin Chim Acta 275 (1998) 127
12. Fusai G., Glantzounis G.K., Hafez T., et al. N-Acetylcysteine ameliorates the late phase of liver ischaemia/reperfusion injury in the rabbit with hepatic steatosis. Clin Sci (Lond) 109 (2005) 465
13. Glantzounis G.K., Yang W., Koti R.S., et al. Continuous infusion of N-acetylcysteine reduces liver warm ischaemia-reperfusion injury. Br J Surg 91 (2004) 1330
14. Reiter R.J., and Tan D.X. Melatonin: A novel protective agent against oxidative injury of the ischemic/reperfused heart. Cardiovasc Res 58 (2003) 10
15. Allegra M., Reiter R.J., Tan D.X., et al. The chemistry of melatonin's interaction with reactive species. J Pineal Res 34 (2003) 1
16. Reiter R.J., Tan D.X., Osuna C., et al. Actions of melatonin in the reduction of oxidative stress. A review. J Biomed Sci 7 (2000) 444
17. Reiter R.J., Tan D.X., Manchester L.C., et al. Biochemical reactivity of melatonin with reactive oxygen and nitrogen species: A review of the evidence. Cell Biochem Biophys 34 (2001) 237
18. Rodriguez C., Mayo J.C., Sainz R.M., et al. Regulation of antioxidant enzymes: A significant role for melatonin. J Pineal Res 36 (2004) 1
19. Mayo J.C., Sainz R.M., Tan D.X., et al. Antiinflammatory actions of melatonin and its metabolites, N1-acetyl-N2-formyl-5-methoxykynuramine (AFMK), and N1-acetyl-5-methoxykynuramine (AMK) in macrophages. J Neuroimmunol 165 (2005) 139
20. Dong G.H., Xu B., Wang C.T., et al. A rat model of cardiopulmonary bypass with excellent survival. J Surg Res 123 (2005) 171
21. Rodriguez-Reynoso S., Leal C., Portilla E., et al. Effect of exogenous melatonin on hepatic energetic status during ischemia/reperfusion: Possible role of tumor necrosis factor-α and nitric oxide. J Surg Res 100 (2001) 141
22. Sigala F., Theocharis S., Sigalas K., et al. Therapeutic value of melatonin in an experimental model of liver injury and regeneration. J Pineal Res 40 (2006) 270
23. Ochoa J.J., Vilchez M.J., Palacios M.A., et al. Melatonin protects against lipid peroxidation and membrane rigidity in erythrocytes from patients undergoing cardiopulmonary bypass surgery. J Pineal Res 35 (2003) 104
24. Lopez-Neblina F., Paez A.J., and Toledo-Pereyra L.H. Modulation of neutrophil infiltration through nitric oxide in the ischemic rat kidney. Transplant Proc 27 (1995) 1883
25. Hsu C.M., Wang J.S., Liu C.H., et al. Kupffer cells protect liver from ischemia-reperfusion injury by an inducible nitric oxide synthase-dependent mechanism. Shock 17 (2002) 280
26. Sener G., Tosun O., Sehirli A.O., et al. Melatonin and N-acetylcysteine have beneficial effects during hepatic ischemia and reperfusion. Life Sci 72 (2003) 2707
27. Angdin M., Settergren G., Starkopf J., et al. Protective effect of antioxidants on pulmonary endothelial function after cardiopulmonary bypass. J Cardiothorac Vasc Anesth 17 (2003) 314
28. Tossios P., Bloch W., Huebner A., et al. N-acetylcysteine prevents reactive oxygen species-mediated myocardial stress in patients undergoing cardiac surgery: results of a randomized, double-blind, placebo-controlled clinical trial. J Thorac Cardiovasc Surg 126 (2003) 1513
29. Ando T., Fujimoto K., Mayahara H., et al. A new one step method for the histochemistry and cytochemistry of Ca++-ATPase activity. Acta Histochem Cytochem 14 (1981) 705
30. Beckman J.S. The double-edged role of nitric oxide in brain function and superoxide-mediated injury. J Dev Physiol 15 (1991) 53
31. Busse R., Fleming I., and Schini V.B. Nitric oxide formation in the vascular wall: Regulation and functional implications. Curr Top Microbiol Immunol 196 (1995) 7
32. Hayashi Y., Sawa Y., Fukuyama N., et al. Inducible nitric oxide production is an adaptation to cardiopulmonary bypass-induced inflammatory response. Ann Thorac Surg 72 (2001) 149
33. Seo M.Y., and Lee S.M. Protective effect of low dose of ascorbic acid on hepatobiliary function in hepatic ischemia/reperfusion in rats. J Hepatol 36 (2002) 72
34. Jefferies H., Coster J., Khalil A., et al. Glutathione. Aust NZ J Surgery 73 (2003) 517